Trial · NCT00570531
Adverse events110
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 110
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Allergic Rhinitis | Immune system disorders | Bevacizumab | 1 | 6 | 1 |
| other | Hemoglobin | Blood and lymphatic system disorders | Bevacizumab | 4 | 6 | 11 |
| other | Leukocytes (total WBC) | Blood and lymphatic system disorders | Bevacizumab | 1 | 6 | 4 |
| other | Lymphopenia | Blood and lymphatic system disorders | Bevacizumab | 2 | 6 | 6 |
| other | Neutrophils/granulocytes (ANC/AGC) | Blood and lymphatic system disorders | Bevacizumab | 2 | 6 | 2 |
| other | Platelets | Blood and lymphatic system disorders | Bevacizumab | 1 | 6 | 1 |
| other | Prolonged QTc interval | Cardiac disorders | Bevacizumab | 1 | 6 | 1 |
| other | Atrial fibrillation | Cardiac disorders | Bevacizumab | 1 | 6 | 4 |
| other | Atrial flutter | Cardiac disorders | Bevacizumab | 2 | 6 | 2 |
| other | Sinus bradycardia | Cardiac disorders | Bevacizumab | 1 | 6 | 1 |
| other | Sinus tachycardia | Cardiac disorders | Bevacizumab | 2 | 6 | 2 |
| other | Ventricular arrhythmia | Cardiac disorders | Bevacizumab | 1 | 6 | 1 |
| other | Cardiac ischemia/infarction | Cardiac disorders | Bevacizumab | 1 | 6 | 1 |
| other | Cardiopulmonary arrest, cause unknown (non-fatal) | Cardiac disorders | Bevacizumab | 1 | 6 | 3 |
| other | Hypertension | Cardiac disorders | Bevacizumab | 1 | 6 | 2 |
| other | Hypotension | Cardiac disorders | Bevacizumab | 2 | 6 | 2 |
| other | INR (International Normalized Ratio of prothrombin time) | Investigations | Bevacizumab | 1 | 6 | 1 |
| other | Fatigue (asthenia, lethargy, malaise) | General disorders | Bevacizumab | 4 | 6 | 6 |
| other | Fever (in the absence of neutropenia) | General disorders | Bevacizumab | 3 | 6 | 3 |
| other | Insomnia | Psychiatric disorders | Bevacizumab | 1 | 6 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00570531/events